Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial
Muskiet, M.H.A., Bunck, M.C., Heine, R.J., Cornér, A., Yki-Järvinen, H., Eliasson, B., Joles, J.A., Diamant, M., Tonneijck, L., van Raalte, D.H.
Published in Diabetes research and clinical practice (01.07.2019)
Published in Diabetes research and clinical practice (01.07.2019)
Get full text
Journal Article
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
Bunck, M.C, Eliasson, B, Cornér, A, Heine, R.J, Shaginian, R.M, Taskinen, M.-R, Yki-Järvinen, H, Smith, U, Diamant, M
Published in Diabetes, obesity & metabolism (01.04.2011)
Published in Diabetes, obesity & metabolism (01.04.2011)
Get full text
Journal Article